X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

VOR

Closed

Vor Biopharma Inc

0.8745
+0.0064 (+0.74%)
Last Update: 24 Dec 2024 21:46:00
Yesterday: 0.8681
Day's Range: 0.8473 - 0.8897
Send
When Written:
 
5
Vor Biopharma Inc. is a clinical-stage biopharmaceutical company that is focused on developing therapies for the treatment of cancer. The company was founded in 2018 and is based in Cambridge, Massachusetts. Vor Biopharma's lead product candidate is VOR33, a potential treatment for acute myeloid leukemia (AML) and other blood cancers. VOR33 is a chimeric antigen receptor T-cell (CAR-T) therapy that is designed to target and destroy cancer cells while leaving healthy cells unharmed. The company is also developing other CAR-T therapies for the treatment of solid tumors. Vor Biopharma has raised over $200 million in funding to date from investors including 5AM Ventures, RA Capital, and Fidelity Management & Research Company.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:3.143.17.175
X